_id

691854303c536f8df23178a2

Ticker

0AB6.LSE

Name

Hyloris Pharmaceuticals S.A.

Exchange

LSE

Address

Boulevard Patience et Beaujonc N°3/1, Liège, Belgium, 4000

Country

UK

Sector

Industry

Currency

EUR

Website

https://hyloris.com

Description

Hyloris Pharmaceuticals SA engages in the research, development, and manufacture of pharmaceutical products to address medical needs. The company offers Maxigesic IV, a combination of paracetamol and ibuprofen used for post-operative pain, the opioid crisis, and acute pain; Podofilox Gel, an antimycotic drug for the treatment of external genital and perianal warts caused by various types of the human papilloma virus; and Sotalol IV to treat atrial fibrillation. It also develops Aspirin IV and HY-074 IV to reduce the risk of morbidity and mortality associated with an emergency cardiac event, such as myocardial infarction or stroke; Milrinone ER for right heart failure due to left ventricular device; Dofetilide IV to treat atrial fibrillation; Metolazone IV for the treatment of salt and water retention, including edema accompanying congestive heart failure and renal diseases; and HY-075 IV to prevent and treat cardiovascular diseases. The company offers other value-added products comprising Tranexamic Acid Oral Rinse for preventing and treating excessive bleeding in patients on blood thinners undergoing dental procedures; Alenura to treat pain associated with interstitial cystitis/bladder pain syndrome; Miconazole/Domiphen Bromide cream to treat vaginal infections caused by candida yeast and/or bacteria, including a biofilm; PTX-252 to treat acute myeloid leukemia; Atomoxetine oral Liquid for the treatment of attention deficit hyperactivity disorder; HY-083 to treat idiopathic rhinitis; HY-088 for hypophosphatemia; HY-090 to treat burning mouth syndrome; HY-091 for vulvar lichen sclerosis; HY-095 to treat equine gastric ulcer; Pantoprazole IV to treat gastric acidity, and ulcers and erosive esophagitis; Ondansetron for nausea and vomiting; and HY-094 to treat iron deficiency. It has collaboration agreement with FHP BV, Pleco Therapeutics, Vaneltix Pharma, Inc., and AFT Pharmaceuticals. The company was incorporated in 2012 and is headquartered in Liège, Belgium.

Last Close

7.54

Volume

2158

Current Price

7.54

Change

0.44

Last Updated

2026-01-08T13:33:19.157Z

Image

https://logo.clearbit.com/hyloris.com

Ipo Date

-

Market Cap

200855440

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2023-06-30

Revenue

-

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

-

Operating Income

-

Interest Expense

-

Pretax Income

-

Net Income

-

Eps

-

Dividends Per Share

-

Shares Outstanding

28000400

Income Tax Expense

-

EBITDA

-

Operating Margin

-

Total Other Income Expense Net

-

Cash

39159000

Short Term Investments

489000

Receivables

4541000

Inventories

-

Total Current Assets

45015000

Property Plant Equipment

1942000

Total Assets

57273000

Payables

3332000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

8550000

Equity

48723000

Bs_currency_symbol

EUR

Depreciation

81500

Change In Working Capital

-

Cash From Operations

-2064500

Capital Expenditures

0

Cash From Investing

-44000

Cash From Financing

-40000

Net Change In Cash

-2148500

Cf_currency_symbol

EUR

PE

-

PB

4.3331243962810175

ROE

-

ROA

-

FCF

-2064500

Fcf Percent

-

Piotroski FScore

0

Health Score

55

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

2.5

Garp Investing Score

1.5

Growth Investing Score

0

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2

Value Investing Score

4

Quarters > 0 > quarter

2023-06-30

Quarters > 0 > income Statement > revenue

-

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

-

Quarters > 0 > income Statement > operating Income

-

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-

Quarters > 0 > income Statement > net Income

-

Quarters > 0 > income Statement > eps

-

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

28000374

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > income Statement > currency_symbol

EUR

Quarters > 0 > balance Sheet > cash

39159000

Quarters > 0 > balance Sheet > short Term Investments

489000

Quarters > 0 > balance Sheet > receivables

4541000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

45015000

Quarters > 0 > balance Sheet > property Plant Equipment

1942000

Quarters > 0 > balance Sheet > total Assets

57273000

Quarters > 0 > balance Sheet > payables

3332000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

8550000

Quarters > 0 > balance Sheet > equity

48723000

Quarters > 0 > balance Sheet > currency_symbol

EUR

Quarters > 0 > cash Flow > net Income

-3317000

Quarters > 0 > cash Flow > depreciation

81500

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-2064500

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-44000

Quarters > 0 > cash Flow > cash From Financing

-40000

Quarters > 0 > cash Flow > net Change In Cash

-2148500

Quarters > 0 > cash Flow > currency_symbol

EUR

Quarters > 0 > ratios > PE

-

Quarters > 0 > ratios > PB

4.3331243962810175

Quarters > 0 > ratios > ROE

-

Quarters > 0 > ratios > ROA

-

Quarters > 0 > ratios > FCF

-2064500

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

55

Quarters > 1 > quarter

2023-03-31

Quarters > 1 > income Statement > revenue

-

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

-

Quarters > 1 > income Statement > operating Income

-

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-

Quarters > 1 > income Statement > net Income

-

Quarters > 1 > income Statement > eps

-

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

-

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-

Quarters > 1 > income Statement > currency_symbol

EUR

Quarters > 1 > balance Sheet > cash

-

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

4541000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

45015000

Quarters > 1 > balance Sheet > property Plant Equipment

1942000

Quarters > 1 > balance Sheet > total Assets

-

Quarters > 1 > balance Sheet > payables

3332000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

6728000

Quarters > 1 > balance Sheet > equity

-

Quarters > 1 > balance Sheet > currency_symbol

EUR

Quarters > 1 > cash Flow > net Income

-3317000

Quarters > 1 > cash Flow > depreciation

81500

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

-2064500

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-44000

Quarters > 1 > cash Flow > cash From Financing

-40000

Quarters > 1 > cash Flow > net Change In Cash

-2148500

Quarters > 1 > cash Flow > currency_symbol

EUR

Quarters > 1 > ratios > PE

-

Quarters > 1 > ratios > PB

-

Quarters > 1 > ratios > ROE

-

Quarters > 1 > ratios > ROA

-

Quarters > 1 > ratios > FCF

-2064500

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

45

Quarters > 2 > quarter

2022-12-31

Quarters > 2 > income Statement > revenue

-

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

-

Quarters > 2 > income Statement > operating Income

-

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-

Quarters > 2 > income Statement > net Income

-

Quarters > 2 > income Statement > eps

-

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

28000374

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-

Quarters > 2 > income Statement > currency_symbol

EUR

Quarters > 2 > balance Sheet > cash

43457000

Quarters > 2 > balance Sheet > short Term Investments

469000

Quarters > 2 > balance Sheet > receivables

5127000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

50801000

Quarters > 2 > balance Sheet > property Plant Equipment

1060000

Quarters > 2 > balance Sheet > total Assets

61864000

Quarters > 2 > balance Sheet > payables

2302000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

6819000

Quarters > 2 > balance Sheet > equity

55045000

Quarters > 2 > balance Sheet > currency_symbol

EUR

Quarters > 2 > cash Flow > net Income

-2914000

Quarters > 2 > cash Flow > depreciation

81500

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

-2064500

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-44000

Quarters > 2 > cash Flow > cash From Financing

-40000

Quarters > 2 > cash Flow > net Change In Cash

-2148500

Quarters > 2 > cash Flow > currency_symbol

EUR

Quarters > 2 > ratios > PE

-

Quarters > 2 > ratios > PB

3.8354586240348807

Quarters > 2 > ratios > ROE

-

Quarters > 2 > ratios > ROA

-

Quarters > 2 > ratios > FCF

-2064500

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

55

Quarters > 3 > quarter

2022-09-30

Quarters > 3 > income Statement > revenue

-

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

-

Quarters > 3 > income Statement > operating Income

-

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-

Quarters > 3 > income Statement > net Income

-

Quarters > 3 > income Statement > eps

-

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

-

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-

Quarters > 3 > income Statement > currency_symbol

EUR

Quarters > 3 > balance Sheet > cash

-

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

-

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

-

Quarters > 3 > balance Sheet > payables

-

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

-

Quarters > 3 > balance Sheet > equity

-

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

0

Quarters > 3 > cash Flow > depreciation

81500

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

-2064500

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-44000

Quarters > 3 > cash Flow > cash From Financing

-40000

Quarters > 3 > cash Flow > net Change In Cash

-2148500

Quarters > 3 > cash Flow > currency_symbol

EUR

Quarters > 3 > ratios > PE

-

Quarters > 3 > ratios > PB

-

Quarters > 3 > ratios > ROE

-

Quarters > 3 > ratios > ROA

-

Quarters > 3 > ratios > FCF

-2064500

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

45

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

8458000

Annuals > 0 > income Statement > cost Of Revenue

227000

Annuals > 0 > income Statement > gross Profit

8231000

Annuals > 0 > income Statement > operating Expenses

14827000

Annuals > 0 > income Statement > operating Income

-6369000

Annuals > 0 > income Statement > interest Expense

77000

Annuals > 0 > income Statement > pretax Income

-6342000

Annuals > 0 > income Statement > net Income

-6342000

Annuals > 0 > income Statement > eps

-0.22649697464755292

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

28000374

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-

Annuals > 0 > income Statement > operating Margin

-75.30148971388036

Annuals > 0 > income Statement > total Other Income Expense Net

-

Annuals > 0 > income Statement > currency_symbol

EUR

Annuals > 0 > balance Sheet > cash

23594000

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

4858000

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

29707000

Annuals > 0 > balance Sheet > property Plant Equipment

1993000

Annuals > 0 > balance Sheet > total Assets

41335000

Annuals > 0 > balance Sheet > payables

3166000

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

9192000

Annuals > 0 > balance Sheet > equity

32143000

Annuals > 0 > balance Sheet > currency_symbol

EUR

Annuals > 0 > cash Flow > net Income

-6342000

Annuals > 0 > cash Flow > depreciation

648000

Annuals > 0 > cash Flow > change In Working Capital

-1338000

Annuals > 0 > cash Flow > cash From Operations

-6903000

Annuals > 0 > cash Flow > capital Expenditures

297000

Annuals > 0 > cash Flow > cash From Investing

-

Annuals > 0 > cash Flow > cash From Financing

-

Annuals > 0 > cash Flow > net Change In Cash

-6812000

Annuals > 0 > cash Flow > currency_symbol

EUR

Annuals > 0 > ratios > PE

-0.22649697464755292

Annuals > 0 > ratios > PB

6.568236317705254

Annuals > 0 > ratios > ROE

-19.730578975204555

Annuals > 0 > ratios > ROA

-15.342929720575782

Annuals > 0 > ratios > FCF

-7200000

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-0.851265074485694

Annuals > 0 > health Score

27

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

2087000

Annuals > 1 > income Statement > cost Of Revenue

93000

Annuals > 1 > income Statement > gross Profit

1994000

Annuals > 1 > income Statement > operating Expenses

17933000

Annuals > 1 > income Statement > operating Income

-15846000

Annuals > 1 > income Statement > interest Expense

52000

Annuals > 1 > income Statement > pretax Income

-15380000

Annuals > 1 > income Statement > net Income

-15380000

Annuals > 1 > income Statement > eps

-0.5492783774959578

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

28000374

Annuals > 1 > income Statement > income Tax Expense

-

Annuals > 1 > income Statement > EBITDA

-

Annuals > 1 > income Statement > operating Margin

-759.2716818399617

Annuals > 1 > income Statement > total Other Income Expense Net

-

Annuals > 1 > income Statement > currency_symbol

EUR

Annuals > 1 > balance Sheet > cash

30406000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

3565000

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

35308000

Annuals > 1 > balance Sheet > property Plant Equipment

2153000

Annuals > 1 > balance Sheet > total Assets

47681000

Annuals > 1 > balance Sheet > payables

3195000

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

8612000

Annuals > 1 > balance Sheet > equity

39069000

Annuals > 1 > balance Sheet > currency_symbol

EUR

Annuals > 1 > cash Flow > net Income

-15762000

Annuals > 1 > cash Flow > depreciation

348000

Annuals > 1 > cash Flow > change In Working Capital

2234000

Annuals > 1 > cash Flow > cash From Operations

-12808000

Annuals > 1 > cash Flow > capital Expenditures

750000

Annuals > 1 > cash Flow > cash From Investing

-

Annuals > 1 > cash Flow > cash From Financing

-

Annuals > 1 > cash Flow > net Change In Cash

-3051000

Annuals > 1 > cash Flow > currency_symbol

EUR

Annuals > 1 > ratios > PE

-0.5492783774959578

Annuals > 1 > ratios > PB

5.4038449911694695

Annuals > 1 > ratios > ROE

-39.36624945609051

Annuals > 1 > ratios > ROA

-32.25603489859692

Annuals > 1 > ratios > FCF

-13558000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-6.496406324868232

Annuals > 1 > health Score

29

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

2951000

Annuals > 2 > income Statement > cost Of Revenue

94000

Annuals > 2 > income Statement > gross Profit

2857000

Annuals > 2 > income Statement > operating Expenses

13459000

Annuals > 2 > income Statement > operating Income

-10508000

Annuals > 2 > income Statement > interest Expense

219000

Annuals > 2 > income Statement > pretax Income

-10766000

Annuals > 2 > income Statement > net Income

-10770000

Annuals > 2 > income Statement > eps

-0.3846377194818898

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

28000374

Annuals > 2 > income Statement > income Tax Expense

4000

Annuals > 2 > income Statement > EBITDA

-10351000

Annuals > 2 > income Statement > operating Margin

-356.0826838359878

Annuals > 2 > income Statement > total Other Income Expense Net

-

Annuals > 2 > income Statement > currency_symbol

EUR

Annuals > 2 > balance Sheet > cash

43457000

Annuals > 2 > balance Sheet > short Term Investments

469000

Annuals > 2 > balance Sheet > receivables

4127000

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

50801000

Annuals > 2 > balance Sheet > property Plant Equipment

1060000

Annuals > 2 > balance Sheet > total Assets

61864000

Annuals > 2 > balance Sheet > payables

2422000

Annuals > 2 > balance Sheet > short Term Debt

-

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

6819000

Annuals > 2 > balance Sheet > equity

55045000

Annuals > 2 > balance Sheet > currency_symbol

EUR

Annuals > 2 > cash Flow > net Income

-10770000

Annuals > 2 > cash Flow > depreciation

196000

Annuals > 2 > cash Flow > change In Working Capital

-3375000

Annuals > 2 > cash Flow > cash From Operations

-13154000

Annuals > 2 > cash Flow > capital Expenditures

101000

Annuals > 2 > cash Flow > cash From Investing

-1239000

Annuals > 2 > cash Flow > cash From Financing

7838000

Annuals > 2 > cash Flow > net Change In Cash

-6555000

Annuals > 2 > cash Flow > currency_symbol

EUR

Annuals > 2 > ratios > PE

-0.3846377194818898

Annuals > 2 > ratios > PB

3.8354586240348807

Annuals > 2 > ratios > ROE

-19.56580979198837

Annuals > 2 > ratios > ROA

-17.409155567050306

Annuals > 2 > ratios > FCF

-13255000

Annuals > 2 > ratios > Piotroski FScore

1

Annuals > 2 > ratios > fcf Percent

-4.491697729583192

Annuals > 2 > health Score

30

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

3096000

Annuals > 3 > income Statement > cost Of Revenue

107000

Annuals > 3 > income Statement > gross Profit

2989000

Annuals > 3 > income Statement > operating Expenses

13444000

Annuals > 3 > income Statement > operating Income

-10348000

Annuals > 3 > income Statement > interest Expense

556000

Annuals > 3 > income Statement > pretax Income

-11282000

Annuals > 3 > income Statement > net Income

-11579000

Annuals > 3 > income Statement > eps

-0.4482315236016214

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

25832632

Annuals > 3 > income Statement > income Tax Expense

297000

Annuals > 3 > income Statement > EBITDA

-10589000

Annuals > 3 > income Statement > operating Margin

-334.2377260981912

Annuals > 3 > income Statement > total Other Income Expense Net

-

Annuals > 3 > income Statement > currency_symbol

EUR

Annuals > 3 > balance Sheet > cash

50012000

Annuals > 3 > balance Sheet > short Term Investments

528000

Annuals > 3 > balance Sheet > receivables

2321000

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

53959000

Annuals > 3 > balance Sheet > property Plant Equipment

295000

Annuals > 3 > balance Sheet > total Assets

63444000

Annuals > 3 > balance Sheet > payables

2622000

Annuals > 3 > balance Sheet > short Term Debt

-

Annuals > 3 > balance Sheet > long Term Debt

300000

Annuals > 3 > balance Sheet > total Liabilities

15388000

Annuals > 3 > balance Sheet > equity

48056000

Annuals > 3 > balance Sheet > currency_symbol

EUR

Annuals > 3 > cash Flow > net Income

-11579000

Annuals > 3 > cash Flow > depreciation

114000

Annuals > 3 > cash Flow > change In Working Capital

-777000

Annuals > 3 > cash Flow > cash From Operations

-11250000

Annuals > 3 > cash Flow > capital Expenditures

107000

Annuals > 3 > cash Flow > cash From Investing

-3075000

Annuals > 3 > cash Flow > cash From Financing

-62000

Annuals > 3 > cash Flow > net Change In Cash

-14387000

Annuals > 3 > cash Flow > currency_symbol

EUR

Annuals > 3 > ratios > PE

-0.4482315236016214

Annuals > 3 > ratios > PB

4.053147271516564

Annuals > 3 > ratios > ROE

-24.094806059597136

Annuals > 3 > ratios > ROA

-18.25074081079377

Annuals > 3 > ratios > FCF

-11357000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-3.66828165374677

Annuals > 3 > health Score

29

Valuation > metrics > PB

4.3331243962810175

Valuation > final Score

36.66875603718982

Valuation > verdict

44.4% Overvalued

Profitability > final Score

50

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.17548180530755494

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

13.509903961584634

Liquidity > metrics > Quick Ratio

13.509903961584634

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

41.64541375965119

Prev Valuations > 2

50

Prev Profitabilities > 0

50

Prev Profitabilities > 1

50

Prev Profitabilities > 2

50

Prev Risks > 0

50

Prev Risks > 1

80

Prev Risks > 2

50

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

50

Updated At

2026-01-20T22:52:25.971Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-03-26

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-